Concentra Group Holdings Parent, Inc. Common Stock (CON)

Concentra Group Holdings Parent (NYSE:CON) reported double-digit revenue and adjusted EBITDA growth for the first quarter of 2026, citing stronger workers' compensation visit volumes, acquisitions and improved cost control as key drivers of the results. Chief Executive Officer Keith Newton said the

Concentra (CON) Q1 2026 Earnings Transcript

Concentra (CON) Q4 2025 Earnings Call Transcript

Concentra (CON) beat Q3 2025 earnings and revenue estimates, raised its full-year guidance, and announced a new $100M stock buyback program.

U.S. stocks plunged Tuesday as President Donald Trump‘s tariffs on key trade partners came into effect, prompting retaliatory measures and intensifying global trade tensions.

Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digested a decline in February's ISM Manufacturing PMI data which fell to 50.3%, down from 50.9% in January. 

Wall Street started the week in the red, as traders weighed the economic and geopolitical fallout from escalating tensions in the Middle East.

Concentra, a subsidiary of select medical, recently priced its IPO at $23.50 per share. Concentra offers occupational health services with 547 centers in 41 states.

Analyst initiates coverage on CON with Buy rating and $29 price target. High-quality healthcare services asset with strong growth potential.

Concentra Group Holdings just reported results for the second quarter of 2024.